Acute exudative polymorphous vitelliform maculopathy is a rare retinal disease characterized by bilateral serous macular detachment and subretinal accumulation of yellowish deposits resembling Best dystrophy lesions. Corticosteroid systemic therapy has been used empirically in the attempt to treat this retinal disorder with mixed results. Thus, the benefit of corticosteroid remains undetermined. To our knowledge, we report the first case of acute exudative polymorphous vitelliform maculopathy (AEPVM) treated in one eye with intravitreal dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, California, USA).
Scupola, A., Abed, E., Sammarco, M. G., Traina, S., Villano, A., Grimaldi, G., Blasi, M. A., Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy, <<EUROPEAN JOURNAL OF OPHTHALMOLOGY>>, 2014; 24 (5): 803-807. [doi:10.5301/ejo.5000477] [http://hdl.handle.net/10807/63456]
Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy
Scupola, Andrea;Abed, Edoardo;Sammarco, Maria Grazia;Traina, Salvatore;Villano, Antonio;Blasi, Maria Antonietta
2014
Abstract
Acute exudative polymorphous vitelliform maculopathy is a rare retinal disease characterized by bilateral serous macular detachment and subretinal accumulation of yellowish deposits resembling Best dystrophy lesions. Corticosteroid systemic therapy has been used empirically in the attempt to treat this retinal disorder with mixed results. Thus, the benefit of corticosteroid remains undetermined. To our knowledge, we report the first case of acute exudative polymorphous vitelliform maculopathy (AEPVM) treated in one eye with intravitreal dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, California, USA).
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
